MarketInOut Stock Screener Log In | Sign Up
 

SynBiotic SE

XETRA • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/19/2026 11:53
SynBiotic SE stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeXETRA
Market Capitalization1.53 mln
Float4.37 mln
Earnings Date04/11/2025

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-1.35
Manipulation likely

Relative Strength

0 / 100
Severely lagging

Debt / Equity

0.08
Debt-free

Pre-Tax Margin

-1,049%
Severely loss-making

ROE

-2.62
Negative

Business Description

SynBiotic SE is a Munich-based company founded in 2017 that develops and sells a range of cannabis and hemp-derived products, including dietary supplements, cosmetics, medical cannabis, and recreational cannabis goods. Its products are designed to help people manage pain, improve sleep, and reduce anxiety, and are sold under several brand names such as Hempamed, Princess Stardust, The Hempany, and Hempamed Rx. The company was previously called Ledgertech SE before adopting its current name.

Key Fundamentals

EPS-1.18
ROE-2.62
RPS2.54
ROIC-2.30
ROA-1.62
Interest Cover-24.58
EBITDA, mln-0.45
EV / EBITDA-20.90
EV / EBIT-13.31
Revenue, mln0.07
EV / Revenue130

Quote Details

Last 0.18
Change -0.03 (-14.29%)
Open 0.20
Volume 70,117
Turnover 12,621
Average Volume 10,750

Financial Ratios

Pre-Tax Profit Margin-1,049
Leverage Ratio2.00
Current Ratio2.77
Price / Book0.17
Price / Tangible Book0.19
Debt / Equity0.08
Price / Sales82.56

Financial Strength

Altman Z-Score-2.28
Piotroski F-Score 2 / 9
Beneish M-Score-1.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -76.65% 0 / 100   
1 Month -80.18% 0 / 100   
2 Months -85% 0 / 100   
6 Months -91.78% 0 / 100   
1 Year -93.18% 0 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us